CTS Corporation Announces Appointment of Kimberly Banks MacKay to its Board of Directors

Rhea-AI Summary

CTS (NYSE: CTS) announced the appointment of Kimberly Banks MacKay to its Board of Directors, effective November 5, 2025. She will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.

Ms. MacKay has over 30 years of experience in multinational companies and currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services. She also holds board and committee roles with the Community Foundation of New Jersey and BAYADA Home Health Care. Company leadership said her healthcare and global business experience supports CTS’s focus on growth, end-market diversification, and its products that sense, connect and move.

LISLE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced that Kimberly Banks MacKay has been appointed to its Board of Directors, effective November 5, 2025, and that she will serve as a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee.

Ms. MacKay comes to CTS with over 30 years of experience driving results in multi-national companies serving key end markets. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKay is also a member of the Board of the Community Foundation of New Jersey, and the Compliance, Audit and Risk Committee for BAYADA Home Health Care.

"CTS is pleased to welcome Kimberly MacKay to the CTS Board. Her extensive experience in healthcare and background leading global businesses make her a valuable addition to our already highly experienced, diverse group of directors, as CTS continues to focus on growth, end-market diversification, and products that sense, connect and move," said Kieran O’Sullivan, Chairman, President and CEO of CTS.

About CTS

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

Contact
Ashish Agrawal
Vice President and Chief Financial Officer

CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA

Telephone: +1 (630) 577-8800
Email: ashish.agrawal@ctscorp.com

FAQ

When did CTS (CTS) appoint Kimberly Banks MacKay to its board?

Kimberly Banks MacKay was appointed to the CTS board effective November 5, 2025.

What committees will Kimberly MacKay join on the CTS board (CTS)?

She will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.

What is Kimberly MacKay’s current role before joining CTS (CTS)?

She currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services.

How does Kimberly MacKay’s background relate to CTS’s strategy (CTS)?

She has 30+ years of multinational experience and healthcare expertise that CTS cites as supporting its growth and end-market diversification focus.

Does Kimberly MacKay hold other board or committee positions while joining CTS (CTS)?

Yes. She is a board member of the Community Foundation of New Jersey and serves on the Compliance, Audit and Risk Committee for BAYADA Home Health Care.